Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.440NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.440NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.82 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.82 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.30NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.23.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.23.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.466.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.466.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.23.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.23.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.104 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.104 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.198NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.198NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.2 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.2 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BL.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
M.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
M.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BZ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BZ.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.10.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.10.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.24NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.44NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.44NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used